<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>23406797</identifier>
<setSpec>1576-8260</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Barba Abad, Javier</dc:author>
<dc:author>Berián Polo, José María</dc:author>
<dc:author>Tienza Fernández, Antonio</dc:author>
<dc:author>Algarra Navarro, Rubén</dc:author>
<dc:author>Pascual Piédrola, Juan Ignacio</dc:author>
<dc:author>Rioja Zuazu, Jorge</dc:author>
<dc:author>Romero Vargas, Luis</dc:author>
<dc:author>Robles García, José Enrique</dc:author>
<dc:author>Zudaire Bergera, Juan Javier</dc:author>
<dc:author>Rosell Costa, David</dc:author>
<dc:author>Rincón Mayans, Aníbal</dc:author>
<dc:description xml:lang="en">Renal cell adenocarcinoma requires different therapeutic pathways because it is one of the most therapy-resistant tumors, on the other hand it is biologically one of the most attractive tumors. Its pathological classification has a genetic base. There is an anomaly of the Von Hippel Lindau gene in 80% of adenocarcinomas, being this fact determinant to know the biological characteristics of tumor initiation and development, as well as the identification of factors susceptible to be used as therapeutic targets. Since 2005 a group of molecules have been used in the treatment of metastatic adenocarcinomas and, even though therapeutic results are significant but not clinically relevant yet, we are sure they are a key way for more efficient future developments. The present study tries to make a tour on the research of the biological anomalies in renal adenocarcinoma with special emphasis in the Von HippelLindau gene.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2013 Jan-Feb </dc:date>
<dc:title xml:lang="es">Biología molecular en adenocarcinoma renal (RCC). Su utilidad pronóstica y terapéutica.</dc:title>
<dc:title xml:lang="en">[Renal cell carcinoma molecular biology. Prognostic and therapeutic usefulness].</dc:title>
<dc:publisher>Archivos espanoles de urologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
